mRNA |
BRD-K34485477 |
CTRPv2 |
pan-cancer |
AAC |
0.17 |
0.02 |
mRNA |
quizartinib |
CTRPv2 |
pan-cancer |
AAC |
-0.084 |
0.02 |
mRNA |
BRD-K51490254 |
CTRPv2 |
pan-cancer |
AAC |
-0.085 |
0.02 |
mRNA |
BRD-K71781559 |
CTRPv2 |
pan-cancer |
AAC |
-0.087 |
0.02 |
mRNA |
BAY 61-3606 |
GDSC1000 |
pan-cancer |
AAC |
-0.076 |
0.02 |
mRNA |
XMD8-85 |
GDSC1000 |
pan-cancer |
AAC |
-0.11 |
0.03 |
mRNA |
L-685458 |
CCLE |
pan-cancer |
AAC |
-0.1 |
0.03 |
mRNA |
CAY10618 |
CTRPv2 |
pan-cancer |
AAC |
0.076 |
0.03 |
mRNA |
doxorubicin:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.07 |
0.03 |
mRNA |
carboplatin:etoposide (40:17 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.064 |
0.03 |